SCHEMBL19869000

SCHEMBL19869000

CC(C)Cc1ccc(-c2nc(-c3ccc(Cl)cc3)c(-c3ccncc3)[nH]2)cc1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 14/20 0.73
MAPK12 P53778 14/20 0.73
MAPK11 Q15759 14/20 0.73
MAPK14 Q16539 14/20 0.73
GCGR P47871 11/20 0.73
RAF1 P04049 4/20 0.67
BRAF P15056 2/20 0.56
ALOX5 P09917 2/20 0.55
MAPK9 P45984 2/20 0.54
PRKD3 O94806 1/20 0.54
MAP4K4 O95819 1/20 0.54
FRK P42685 1/20 0.54
CSNK1A1 P48729 1/20 0.54
CSNK1D P48730 1/20 0.54
GSK3B P49841 1/20 0.54
PTK6 Q13882 1/20 0.54
PRKD2 Q9BZL6 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19868929 0.89 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL19868996 0.88 MAPK14 (0.67) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL19857273 0.88 MAPK11 (0.73) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL19868999 0.86 MAPK13 (0.68) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6471005 0.85 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2649730 0.85 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6465608 0.85 MAPK13 (0.81) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL19868998 0.84 ALOX5 (0.70) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2647350 0.82 GCGR (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL19868942 0.81 MAPK14 (0.46) MAPK13MAPK12MAPK11MAPK14GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS CREB1, PPP6R1, PPP1R10 MAPK13 782/4885MAPK12 363/4885MAPK11 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.